Viewing Study NCT06673667

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2026-02-27 @ 3:44 PM
Study NCT ID: NCT06673667
Status: COMPLETED
Last Update Posted: 2025-10-02
First Post: 2024-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants
Sponsor: Kymera Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Participants Study View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None STAT6 View
None STAT6 degrader View
None targeted protein degrader View